Who’s at greater risk for long-COVID? New study sheds light on vulnerable demographics

A study analyzing 134,444 participants from BRFSS and NHIS reveals that 21.5% and 17.1% respectively suffer from long-COVID, with higher risks in middle-aged, female, Hispanic individuals, those with less education, and residents of certain areas.

Information blocking fines are now fair game in health care

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in

September 5, 2023

FDA finds ‘potential systemic bias’ in Amgen’s KRAS drug trial ahead of advisory meeting

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday

October 3, 2023

Beleaguered drug manufacturer Emergent cuts jobs, executive role in business shake-up

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.